After four teenage girls involved in a clinical trial in India testing vaccines for human papillomavirus (HPV) died last year, the study "threatens to have a dual legacy: inflaming unfounded fears about a lifesaving vaccine and raising new questions about the management of medical research in the country," Nature News reports.
Results of a major trial of hormone therapy on men with locally advanced prostate cancer announced today were a significant development and would be welcomed by patients and oncologists world-wide, according to The Cancer Council Australia.
Results of a major trial of hormone therapy on men with locally advanced prostate cancer announced today were a significant development and would be welcomed by patients and oncologists world-wide, according to The Cancer Council Australia.
Sexually active gay men are many times more likely than others to acquire a new, highly antibiotic-resistant strain of the so-called MRSA bacteria widely know as the "superbug," a UCSF-led study shows.
BBC News Magazine examines an antiviral drug called Draco, developed by Todd Rider, a research scientist at the Massachusetts Institute of Technology, "which has proven successful against all 15 viruses to which it has been applied in lab trials with human tissue and mice," including "the common cold, H1N1 or swine flu, a polio virus, dengue fever, and the notorious and fatal Ebola virus."
U.S. News & World Report examines the growing epidemic of drug-resistant tuberculosis (TB), highlighting a "new paper published earlier this week in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal warn[ing] that the first cases of 'totally drug-resistant' tuberculosis have been found in South Africa and that the disease is 'virtually untreatable."
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
AOL News examines health officials' concerns about the world-wide spread of drug-resistant strains of tuberculosis, focusing on the U.S. and Mexico.